Publisher profile

outbreaknewstoday.substack.com

Official domain outbreaknewstoday.substack.com

Explore recent coverage from this publisher, with reporting context brought together on Scroll News.

Coverage 7 articles tracked
Visit official website

Reporting, in context

Latest coverage

7 stories
  • 😐 Azerbaijan health officials deny mumps epidemic in Baku · health

    The Ministry of Health of the Republic of Azerbaijan reports posts have been circulating on social networks about the widespread spread of epidemic mumps in Baku do not reflect the current epidemiological situation. Health officials say the epidemiological situation of mumps in the country is stable. The registered cases of infection consist of individual sporadic cases, no epidemics or mass spread have been recorded. The current situation is constantly under epidemiological surveillance by relevant medical institutions, and the necessary preventive and counter-epidemic measures are consistently implemented. Epidemic mumps is observed more often among unvaccinated or incompletely vaccinated individuals. The disease is transmitted mainly by airborne droplets - during coughing, sneezing and close contact. The incubation period usually lasts 11–23 days. The main symptoms of the disease are fever, swelling and pain in the parotid salivary glands, discomfort when chewing and swallowing, general weakness, headache and loss of appetite. In most cases, mumps is mild and results in complete recovery. However, in rare cases, certain complications may develop in unvaccinated adolescents and adults. Therefore, timely vaccination is of particular importance in preventing the disease. Subscribe to Outbreak News TV on YouTube In accordance with the National Vaccination Schedule in Azerbaijan, the combined measles, mumps, and rubella (MMR) vaccine is administered to children at 12 months of age, with a booster dose at 6 years of age. The MMR vaccine is the most reliable and effective means of protection against mumps. The Ministry of Health recommends that parents check their children’s vaccination status. If for any reason the vaccination has been delayed or missed, it is recommended to contact the medical facility in your area of ​​residence and consult a doctor. To protect yourself from the disease, it is recommended to follow preventive measures such as avoiding close contact with sick people, following personal hygiene rules, washing hands regularly, and frequently ventilating closed spaces. If you experience symptoms of the disease, avoid self-medication, seek medical attention, and do not return to work until you are fully recovered. Citizens are asked to refer only to official sources and not to believe or share unverified information circulating on social networks. Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe

    #Baku #MMR Health Technology
    Emotions: ahah 43% · wow 29%
  • 😐 Algeria eliminates trachoma as a public health problem · health

    The World Health Organization (WHO) reports validating Algeria as having eliminated trachoma as a public health problem. This makes Algeria the 29th country globally to achieve this significant milestone. "Algeria’s elimination of trachoma is a historic triumph that connects the past, present, and future of public health, and is rooted in a century-long commitment," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "This milestone proves that with sustained political will and on-the-ground leadership from committed health professionals, we can eliminate neglected tropical diseases and build a healthier, more resilient future for all." For decades, Algeria implemented the WHO-recommended SAFE strategy to eliminate trachoma. These activities included provision of surgery to treat the late blinding stage of the disease (“trachomatous trichiasis”, TT), conducting mass administration of antibiotic treatment, carrying out public awareness campaigns to promote facial cleanliness and personal hygiene as well as improvement in access to water supply and sanitation. Trachoma is the first neglected tropical disease to be eliminated in Algeria. Trachoma is a disease of the eye caused by infection with the bacterium Chlamydia trachomatis. It is a public health problem in 30 countries and is responsible for the blindness or visual impairment of about 1.9 million people. Blindness from trachoma is difficult to reverse. Based on November 2025 data, 97 million people live in trachoma endemic areas and are at risk of trachoma blindness. Infection spreads through personal contact (via hands, clothes, bedding or hard surfaces) and by flies that have been in contact with discharge from the eyes or nose of an infected person. With repeated episodes of infection over many years, the eyelashes may be drawn in so that they rub on the surface of the eye. This causes pain and may permanently damage the cornea. In 2024, 87,349 people received surgical treatment for advanced stage of the disease, and 44.4 million people were treated with antibiotics. Global antibiotic coverage in 2024 was 39%. Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe

    #Algeria #Trachoma Technology Health
    Emotions: ahah 50% · wow 50%

Follow a story across time

News Trails

Explore editorial and community perspectives on connected reporting.

Distinct perspectives · No trails available yet

Editorial perspective Editor's News Trails

Editor's News Trails

Publisher-associated editorial trails will appear here when an editorial publishing workflow is available.

Editorial trails are not available yet Unavailable
Community perspective Reader News Trails

Reader News Trails

Public reader-created trails featuring this publisher's coverage are not shown until privacy-safe discovery is available.

Public reader trails are not available yet Unavailable

Explore the reporting

Coverage topics

Browse recurring subjects across this publisher's coverage.

Publisher-specific topics

Publisher-specific topics

Topic discovery is not available for this publisher yet.